ClinConnect ClinConnect Logo
Search / Trial NCT06405373

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · May 6, 2024

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Diabetes Type 1 Diabetes Diabetes Distress T1 D Emotional Distress Telehealth Smart Design

ClinConnect Summary

This clinical trial is focused on finding ways to help adults with type 1 diabetes feel less stressed and overwhelmed by their condition. Participants will be grouped into two different virtual sessions, where they will learn either emotional coping strategies or problem-solving techniques to manage their diabetes distress. After these initial sessions, participants will complete surveys to see how well they responded to the program. If someone doesn’t feel like the first approach worked for them, they will have the chance to join a different, more personalized session to learn additional strategies.

To be eligible for this trial, you need to be at least 30 years old and have type 1 diabetes or a similar condition called latent autoimmune diabetes in adults (LADA). It’s also important that you have a higher level of diabetes-related distress, as measured by a specific survey. Participants must be able to attend weekly virtual sessions and speak English. However, individuals with certain medical, psychiatric conditions, or cognitive impairments may not be able to participate. This study aims to provide valuable tools for managing the emotional challenges of living with diabetes, ultimately improving participants' quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults 30 years and older
  • Type 1 diabetes OR latent autoimmune diabetes in adults (LADA) clinically managed as type 1 diabetes
  • Elevated diabetes distress, defined as a score \>= 2.0 on the T1-DDAS core scale
  • English speaking
  • Exclusion Criteria:
  • Does not receive diabetes care at UNC Endocrinology at Eastowne
  • Cannot commit to the pre-scheduled weekly, virtual sessions
  • Diagnosis of any major medical or psychiatric condition that would preclude participation
  • Diagnosis of dementia or other conditions that affect memory or information retention, such as cognitive impairment
  • Visual or auditory impairment that would interfere with participation in a group intervention
  • Receiving inpatient psychiatric treatment or history of a suicide attempt within the past 12 months at the time of enrollment

About University Of North Carolina, Chapel Hill

The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.

Locations

Chapel Hill, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Anna Kahkoska, MD, PhD

Principal Investigator

University of North Carolina, Chapel Hill

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported